CompletedPhase 2NCT00450255

VEGF Trap in Treating Patients With Recurrent Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery

Studying Twin-reversed arterial perfusion sequence

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
National Cancer Institute (NCI)
Principal Investigator
Ahmad Tarhini
University of Pittsburgh
Intervention
ziv-aflibercept(biological)
Enrollment
41 enrolled
Eligibility
18-120 years · All sexes
Timeline
20072011

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00450255 on ClinicalTrials.gov

Other trials for Twin-reversed arterial perfusion sequence

Additional recruiting or active studies for the same condition.

See all trials for Twin-reversed arterial perfusion sequence

← Back to all trials